Facebook Instagram Twitter RSS Feed Back to top on side

Odbor medzinárodnej spolupráce informuje

NEURON Cofund2: Pre-announcement: JTC2022 „Cerebrovascular Diseases“

20. 12. 2021 | zhliadnuté 64-krát

Preliminary Announcement

Call proposal for

MULTINATIONAL AND TRANSLATIONAL RESEARCH PROJECTS ON

CEREBROVASCULAR DISEASES INCLUDING SMALL VESSEL AND BRAIN BARRIERS DYSFUNCTION

 

Aim and scope of the call

The aim of the call is to facilitate multinational, collaborative research projects that will address important translational questions in the areas of stroke and other cerebrovascular diseases including small vessels disease (CSVD) and the dysfunction of brain barriers.
Research proposals should cover at least one of the following areas:
a) Fundamental research addressing the pathogenesis, aetiology, progression, treatment, and prevention of cerebrovascular diseases including CSVD as well as basic research to elucidate the role of brain barriers on cerebrovascular diseases. This may include the development of innovative or shared resources and technologies including computational and statistical tools, as considered of relevance in the context of this call.
b) Clinical research to develop novel strategies for prevention (including secondary prevention), diagnosis, patient stratification, therapy and/or rehabilitation for cerebrovascular diseases

The following research areas are excluded from this call:

• Neurodegenerative disorders that are addressed by the EU Joint Programme –
Neurodegenerative Disease Research (JPND)2.
• Proposals focussed primarily on cardiological or metabolic causes or comorbidities (i.e. diabetes, obesity, Covid-19/long Covid) to cerebrovascular diseases.
 

Timetable

The launch of the call is scheduled on January 7, 2022.
The deadline for submitting the pre-proposals is scheduled in March 2022.
By mid-May 2022 the coordinators of selected pre-proposals will be invited by the Joint Call Secretariat to submit a full proposal by June 2022.
ERA-NET NEURON JTC 2022 Preliminary announcement
Page 6 of 6
Funding is expected to start early in 2023.